Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vincent Algalarrondo, Teresa Antonini, Marie Théaudin, Denis Chemla, Anouar Benmalek, Denis Castaing, Cécile Cauquil, François Rouzet, Delphine Mika, Eric Duong, Sylvie Dinanian, Ludivine Eliahou, Dominique Le Guludec, Didier Samuel, David Adams & Michel S. Slama. (2018) Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy. Amyloid 25:4, pages 253-260.
Read now
Read now
Zhijian Duan & Ai-Ming Yu. (2016) Bioengineered non-coding RNA agent (BERA) in action. Bioengineered 7:6, pages 411-417.
Read now
Read now
Paola Marmiroli & Guido Cavaletti. (2016) Drugs for the treatment of peripheral neuropathies. Expert Opinion on Pharmacotherapy 17:3, pages 381-394.
Read now
Read now
Articles from other publishers (16)
Roxane Bunod, David Adams, Cécile Cauquil, Bruno Francou, Céline Labeyrie, Halima Bourenane, Clovis Adam, Vincent Algalarrondo, Michel Slama, Martha Darce-Bello, Emmanuel Barreau, Marc Labetoulle & Antoine Rousseau. (2020) Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis. British Journal of Ophthalmology 104:10, pages 1363-1367.
Crossref
Crossref
Ines Losada, Juan González‐Moreno, Adrian Rodriguez, Mercedes Uson, Tomas Ripoll‐Vera, Asuncion Ferrer‐Nadal, Elena Rigo, Hernan Andreu, Antoni Figuerola, Juan Carles Montalà, Cristina Descals, Jorge Álvarez, Francisco Vega‐Mañés, Antonia Roig & Eugenia Cisneros‐Barroso. (2020) Multidisciplinary approach in the management of hATTR. European Journal of Clinical Investigation 50:10.
Crossref
Crossref
Andreas Thimm, Saskia Bolz, Michael Fleischer, Benjamin Stolte, Sebastian Wurthmann, Andreas Totzeck, Alexander Carpinteiro, Peter Luedike, Maria Papathanasiou, Christoph Rischpler, Ken Herrmann, Tienush Rassaf, Lars Steinmüller-Magin, Christoph Kleinschnitz & Tim Hagenacker. (2019) Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas. Neurological Research and Practice 1:1.
Crossref
Crossref
Yo‐Tsen Liu, Yueh‐Jung Yen, Frans Ricardo, Yu Chang, Pei‐Hao Wu, Shing‐Jong Huang, Kon‐Ping Lin & Tsyr‐Yan Yu. (2019) Biophysical characterization and modulation of Transthyretin Ala97Ser. Annals of Clinical and Translational Neurology 6:10, pages 1961-1970.
Crossref
Crossref
Paulo J.C. Lin & Ying K. Tam. 2019. Nucleic Acid Nanotheranostics. Nucleic Acid Nanotheranostics
277
310
.
Teodorico C. Ramalho, Alexandre A. de Castro, Tássia S. Tavares, Maria C. Silva, Daniela R. Silva, Pedro H. Cesar, Lucas A. Santos, Elaine F.F. da Cunha, Eugenie Nepovimova & Kamil Kuca. (2018) Insights into the pharmaceuticals and mechanisms of neurological orphan diseases: Current Status and future expectations. Progress in Neurobiology 169, pages 135-157.
Crossref
Crossref
Ravinder Malik, Jing Di, Gayatri Nair, Aida Attar, Karen Taylor, Edmond Teng, Frank-Gerrit Klärner, Thomas Schrader & Gal Bitan. 2018. Peptide Self-Assembly. Peptide Self-Assembly
369
386
.
Vincent Algalarrondo, Teresa Antonini, Marie Théaudin, Denis Chemla, Anouar Benmalek, Catherine Lacroix, Denis Castaing, Cécile Cauquil, Sylvie Dinanian, Ludivine Eliahou, Didier Samuel, David Adams, Dominique Le Guludec, Michel S. Slama & François Rouzet. (2016) Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation. JACC: Cardiovascular Imaging 9:12, pages 1432-1441.
Crossref
Crossref
Nádia Pereira Gonçalves, Paula Gonçalves, Joana Magalhães, Miguel Ventosa, Ana Varela Coelho & Maria João Saraiva. (2016) Tissue remodeling after interference RNA mediated knockdown of transthyretin in a familial amyloidotic polyneuropathy mouse model. Neurobiology of Aging 47, pages 91-101.
Crossref
Crossref
Hartmut H.‐J. Schmidt, Fabio Barroso, Alejandra González‐Duarte, Isabel Conceição, Laura Obici, Denis Keohane & Leslie Amass. (2016) Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy. Muscle & Nerve 54:3, pages 353-360.
Crossref
Crossref
Pui Yan Ho & Ai‐Ming Yu. (2016)
Bioengineering of noncoding
RNAs
for research agents and therapeutics
. WIREs RNA 7:2, pages 186-197.
Crossref
Crossref
Laura Obici, Jan B. Kuks, Juan Buades, David Adams, Ole B. Suhr, Teresa Coelho & Theodore Kyriakides. (2016) Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Current Opinion in Neurology 29:Supplement 1, pages S27-S35.
Crossref
Crossref
David Adams, Ole B. Suhr, Ernst Hund, Laura Obici, Ivailo Tournev, Josep M. Campistol, Michel S. Slama, Bouke P. Hazenberg & Teresa Coelho. (2016) First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Current Opinion in Neurology 29:Supplement 1, pages S14-S26.
Crossref
Crossref
Yesim Parman, David Adams, Laura Obici, Lucía Galán, Velina Guergueltcheva, Ole B. Suhr & Teresa Coelho. (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe. Current Opinion in Neurology 29:Supplement 1, pages S3-S13.
Crossref
Crossref
Márcia Waddington Cruz & Merril D. Benson. (2015) A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis. Neurology and Therapy 4:2, pages 61-79.
Crossref
Crossref
Shijie Liu. (2015) A review on protein oligomerization process. International Journal of Precision Engineering and Manufacturing 16:13, pages 2731-2760.
Crossref
Crossref